Literature DB >> 22338058

Thymomas II: a clinicopathologic correlation of 250 cases with a proposed staging system with emphasis on pathologic assessment.

Cesar A Moran1, Garrett Walsh, Saul Suster, Larry Kaiser.   

Abstract

We present 250 cases of thymomas with emphasis on their clinical staging and follow-up. The patients were 120 males and 130 females between the ages of 13 and 92 years. Surgical resection was performed and histopathologic material evaluated in every case. Grossly, the tumors resected varied in size from 3 to 20 cm in greatest diameter. According to our proposed staging system, 31 cases were stage 0, 128 were stage I, 70 stage II, and 21 stage III at the time of resection. Histologically, approximately 53% of thymomas were of mixed histologic types. Follow-up information ranging from 1 to 16 years was obtained, showing significant statistical P values of .044 and .016 for overall and recurrence-free survival, respectively. We consider that our proposed staging system offers better stratification of cases and improved histologic definitions for proper staging of cases of thymoma.

Entities:  

Mesh:

Year:  2012        PMID: 22338058     DOI: 10.1309/AJCP36ALGUZWOSEA

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  9 in total

1.  The impact of neoadjuvant chemotherapy on the histopathological assessment of thymomas: a clinicopathological correlation of 28 cases treated with a similar regimen.

Authors:  Annikka Weissferdt; Cesar A Moran
Journal:  Lung       Date:  2013-05-08       Impact factor: 2.584

2.  Pretreatment biopsy for thymic epithelial tumors-does histology subtype matter for treatment strategy?

Authors:  Sukhmani K Padda; Marlies Keijzers; Heather A Wakelee
Journal:  J Thorac Dis       Date:  2016-08       Impact factor: 2.895

Review 3.  Expression of cell cycle and apoptosis regulators in thymus and thymic epithelial tumors.

Authors:  Alexandra Papoudou-Bai; Alexandra Barbouti; Vassiliki Galani; Kalliopi Stefanaki; Dimitra Rontogianni; Panagiotis Kanavaros
Journal:  Clin Exp Med       Date:  2015-03-21       Impact factor: 3.984

4.  Thymomas With Intravascular and Intracardiac Growth.

Authors:  Andrea Valeria Arrossi; Josephine K Dermawan; Michael Bolen; Daniel Raymond
Journal:  Front Oncol       Date:  2022-06-24       Impact factor: 5.738

5.  FDG PET-CT aids in the preoperative assessment of patients with newly diagnosed thymic epithelial malignancies.

Authors:  Marcelo F K Benveniste; Cesar A Moran; Osama Mawlawi; Patricia S Fox; Stephen G Swisher; Reginald F Munden; Edith M Marom
Journal:  J Thorac Oncol       Date:  2013-04       Impact factor: 15.609

6.  Expression of PD-1 and PD-L1 in thymic epithelial neoplasms.

Authors:  Annikka Weissferdt; Junya Fujimoto; Neda Kalhor; Jaime Rodriguez; Roland Bassett; Ignacio I Wistuba; Cesar A Moran
Journal:  Mod Pathol       Date:  2017-03-10       Impact factor: 7.842

7.  Patterns of metastasis and recurrence in thymic epithelial tumours: longitudinal imaging review in correlation with histological subtypes.

Authors:  A Khandelwal; L M Sholl; T Araki; N H Ramaiya; H Hatabu; M Nishino
Journal:  Clin Radiol       Date:  2016-06-03       Impact factor: 2.350

8.  Oncological resection, myasthenia gravis and staging as prognostic factors in thymic tumours: a Chilean case series.

Authors:  Patricio Salas; Maria Eliana Solovera; Felipe Bannura; Matias Muñoz-Medel; Miguel Cordova-Delgado; Cesar Sanchez; Carolina Ibañez; Marcelo Garrido; Erica Koch; Francisco Acevedo; Sebastian Mondaca; Bruno Nervi; Jorge Madrid; Jose Peña; Mauricio P Pinto; José Valbuena; Hector Galindo
Journal:  Ecancermedicalscience       Date:  2021-03-09

Review 9.  An overview on the differential diagnostics of tumors of the anterior-superior mediastinum: the pathologist's perspective.

Authors:  Mirella Marino; Stefano Ascani
Journal:  Mediastinum       Date:  2019-02-22
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.